These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7238086)

  • 1. Salbutamol and cardiac arrhythmias.
    Crawford SM; Miles DW
    Curr Med Res Opin; 1981; 7(6):410-5. PubMed ID: 7238086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease.
    Crane J; Burgess CD; Graham AN; Maling TJ
    N Z Med J; 1987 May; 100(824):309-11. PubMed ID: 3330186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Salbutamol therapy of chronic bronchopathic patients with cardiac arrhythmias].
    Del Torre L; Fiore G; Macluso S; Pesce L
    Torace; 1976 Jan; 18(1-2):40-51. PubMed ID: 996855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the heart rhythm and slow-release beta-2 agonist therapy (peroral) in asthmatic patients. A Holter study].
    Malerba M; Politi A; Filippi B; Zambruni U; Grassi V
    Recenti Prog Med; 1992 Dec; 83(12):665-71. PubMed ID: 1494703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Behavior of hemodynamic and blood-gas parameters after intravenous salbutamol].
    Grandillo F; Cacciapuoti F; Giunta R; Gentile S; Falciano A; Varricchio M
    Arch Sci Med (Torino); 1980; 137(3):433-42. PubMed ID: 7235931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combined use of intravenous salbutamol and aminophylline on cardiac rhythm in chronic obstructive lung disease.
    Bigi R; Camerone G; Corradetti C; Durante V; Occhi G; Toloni V
    Respiration; 1987; 51(2):119-26. PubMed ID: 3589176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral doxophylline in patients with chronic obstructive pulmonary disease.
    Villani F; De Maria P; Ronchi E; Galimberti M
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of salbutamol on oxygen saturation in COPD.
    Charoenratanakul S; Borrirukwanit K
    J Med Assoc Thai; 1996 Apr; 79(4):218-21. PubMed ID: 8708506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polygraphic study of systolic rates after intravenous administration of salbutamol].
    Grandillo F; Cacciapuoti F; Rosato G; Giunta R; Spiezia R; Varricchio M
    Arch Sci Med (Torino); 1980; 137(3):443-7. PubMed ID: 7235932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Salbutamol in the treatment of functional broncho-obstructive syndromes].
    Fiora L
    Minerva Med; 1976 Apr; 67(17):1165-75. PubMed ID: 1264395
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute hemodynamic and arrhythmogenic effects of high-dose intravenous salbutamol in patients with chronic left ventricular dysfunction.
    Rotstein Z; Battler A; Rath S; Perek J; Eldar M
    Clin Cardiol; 1990 Jul; 13(7):468-72. PubMed ID: 2364580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of salbutamol in patients with chronic obstructive lung disease (author's transl)].
    Pasquis P; Nouvet G; Denis P; David P; Lefrançois R; Morère P
    Therapie; 1981; 36(1):81-5. PubMed ID: 7233376
    [No Abstract]   [Full Text] [Related]  

  • 13. Electrophysiologic effects of salbutamol, a beta2-selective agonist.
    Insulander P; Juhlin-Dannfelt A; Freyschuss U; Vallin H
    J Cardiovasc Electrophysiol; 2004 Mar; 15(3):316-22. PubMed ID: 15030423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect duration and treatment effectiveness of salmeterol, fenoterol and salbutamol in severe forms of respiratory tract obstruction].
    Vollmer M; Schmidt EW; Ulmer WT
    Pneumologie; 1995 Oct; 49(10):528-34. PubMed ID: 8584522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and ventilatory effects of intravenous salbutamol in patients affected by cold.
    Iodice F; Rufolo L; Piscione F; De Michele G
    Respiration; 1980; 40(5):272-7. PubMed ID: 7232877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline and salbutamol in combination in patients with obstructive pulmonary disease and concurrent heart disease: effect on cardiac arrhythmias.
    Poukkula A; Korhonen UR; Huikuri H; Linnaluoto M
    J Intern Med; 1989 Oct; 226(4):229-34. PubMed ID: 2681505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inhalational bronchodilator treatment during noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations.
    Mukhopadhyay A; Dela Pena E; Wadden B; Procyshyn M; Keang Lim T
    J Crit Care; 2009 Sep; 24(3):474.e1-5. PubMed ID: 19664528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms by which systemic salbutamol increases ventilation.
    Tobin AE; Pellizzer AM; Santamaria JD
    Respirology; 2006 Mar; 11(2):182-7. PubMed ID: 16548904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Air-driven nebulised high-dose salbutamol in severe chronic obstructive airways disease: is it safe?
    Lai CK; Legge JS; Friend JA
    Respiration; 1991; 58(5-6):249-54. PubMed ID: 1792412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experience with delayed-action salbutamol].
    Zanotelli F
    Minerva Med; 1976 Mar; 67(16):1019-22. PubMed ID: 1264374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.